Literature DB >> 27746200

Effect of Balloon Pulmonary Angioplasty on Respiratory Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Mina Akizuki1, Naoki Serizawa2, Atsuko Ueno2, Taku Adachi3, Nobuhisa Hagiwara2.   

Abstract

BACKGROUND: Balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension (CTEPH) improves hemodynamics and exercise capacity. However, its effect on respiratory function is unclear. Our objective was to investigate the effect of BPA on respiratory function.
METHODS: We enrolled patients with inoperable CTEPH who underwent BPA primarily in lower lobe arteries (first series) and upper and middle lobe arteries (second series). We compared changes in hemodynamics and respiratory function between different BPA fields.
RESULTS: Sixty-two BPA sessions were performed in 13 consecutive patients. Mean pulmonary arterial pressure and pulmonary vascular resistance significantly improved from 44 ± 8 to 23 ± 5 mm Hg and 818 ± 383 to 311 ± 117 dyne/s/cm-5. The percent predicted diffusion capacity of lung for carbon monoxide (Dlco) decreased after BPA in the lower lung field (from 60% ± 8% to 54% ± 8%) with no recovery. Percent Dlco increased after BPA in the upper middle lung field (from 53% ± 6% to 58% ± 6%) and continued to improve during the follow-up (from 58% ± 6% to 64% ± 11%). The ventilation/Co2 production (V˙e/V˙co2) slope significantly improved after BPA in the lower lung field (from 51 ± 13 to 41 ± 8) and continued to improve during the follow-up (from 41 ± 8 to 35 ± 7); however, the V˙e/V˙co2 slope remained unchanged after BPA in the upper/middle lung field. Changes in % Dlco and the V˙e/V˙co2 slope differed significantly between lower and upper/middle lung fields.
CONCLUSIONS: The effect of BPA on respiratory function in patients with CTEPH differed depending on the lung field.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; respiratory function

Mesh:

Substances:

Year:  2016        PMID: 27746200     DOI: 10.1016/j.chest.2016.10.002

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Impact of Balloon Pulmonary Angioplasty on Hemodynamics and Clinical Outcomes in Patients with Chronic Thromboembolic Pulmonary Hypertension: the Initial Korean Experience.

Authors:  Woochan Kwon; Jeong Hoon Yang; Taek Kyu Park; Sung A Chang; Dong Seop Jung; Young Seok Cho; Sung Mok Kim; Tae Jung Kim; Hye Yoon Park; Seung Hyuk Choi; Duk Kyung Kim
Journal:  J Korean Med Sci       Date:  2018-01-22       Impact factor: 2.153

2.  Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.

Authors:  Qi Jin; Qin Luo; Tao Yang; Qixian Zeng; Xue Yu; Lu Yan; Yi Zhang; Qing Zhao; Xiuping Ma; Chenhong An; Changming Xiong; Zhihui Zhao; Zhihong Liu
Journal:  Respir Res       Date:  2019-11-08

3.  Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Xin Li; Yi Zhang; Qin Luo; Qing Zhao; Qixian Zeng; Tao Yang; Qi Jin; Lu Yan; Anqi Duan; Jiaran Liu; Chenhong An; Xiuping Ma; Changming Xiong; Zhihui Zhao; Zhihong Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-02

4.  Different response of the oxygen pathway in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy versus balloon pulmonary angioplasty.

Authors:  Zhihui Fu; Xincao Tao; Wanmu Xie; Peiran Yang; Qian Gao; Jinzhi Wang; Zhenguo Zhai
Journal:  Front Cardiovasc Med       Date:  2022-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.